A meta-research study revealed several challenges in obtaining placebos for investigator-initiated drug trials
To systematically assess the kind of placebos used in investigator-initiated randomized controlled trials (RCTs), from where they are obtained, and the hurdles that exist in obtaining them.
Study Design and Setting:
PubMed was searched for recently published noncommercial, placebo-controlled randomized drug trials. Corresponding authors were invited to participate in an online survey.
- Publication status:
- Peer review status:
- Peer reviewed
(Version of record, 315.7KB)
- Publisher copy:
- Copyright holder:
- Speich et al.
- Copyright date:
- Rights statement:
- © 2020 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license.
If you are the owner of this record, you can report an update to it here: Report update to this record